Zura Bio Ltd (ZURA)
2.77
-0.16
(-5.46%)
USD |
NASDAQ |
Nov 22, 11:43
Zura Bio Total Assets (Quarterly): 189.07M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 189.07M |
| June 30, 2024 | 189.50M |
| March 31, 2024 | 90.48M |
| December 31, 2023 | 100.84M |
| September 30, 2023 | 104.59M |
| Date | Value |
|---|---|
| June 30, 2023 | 113.33M |
| March 31, 2023 | 44.38M |
| September 30, 2022 | 5.171M |
| June 30, 2022 | 5.58M |
| March 31, 2022 | 4.72M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
4.72M
Minimum
Mar 2022
189.50M
Maximum
Jun 2024
84.77M
Average
95.66M
Median
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp | 24.07M |
| AIM ImmunoTech Inc | 13.59M |
| IGC Pharma Inc | 10.37M |
| NovaBay Pharmaceuticals Inc | 3.877M |
| Protalix BioTherapeutics Inc | 61.56M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 18.24M |
| Shareholders Equity (Quarterly) | 153.05M |